Plain-English translation of NCT06259669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are following pregnant women with mild to moderate eczema to see if using during pregnancy affects the health of the mother, baby, or infant. This study compares women who used the medication during pregnancy with women who did not use it. The goal is to understand whether this newer eczema treatment is safe to use while pregnant.
Pregnant women with eczema need safe treatment options, but there isn't enough real-world information about how this newer medication affects pregnancy and infant outcomes. This study will help doctors and patients make informed decisions about using this treatment during pregnancy.
You likely qualify if…
You likely don't qualify if…
You would enroll by contacting the study team by phone, either while you are pregnant (preferred) or within 12 months after your baby is born. The researchers will gather information from your medical records and your baby's medical records to track how the pregnancy went and how you and your infant are doing. You may be contacted for follow-up information at various points, and the study team will work with your doctor to get the necessary health information.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Incyte Corporation
Enrollment target
~958 participants
Started
September 2023
Primary completion
August 2032
Age range
15 Years – 50 Years
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Syneos Health
Incyte Corporation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.